VENCLYXTO – (venetoclax)

Venclyxto is an anticancer medicine used to treat adult patients with the following blood cancers:

• Chronic lymphocytic leukemia (CLL): used in combination with other anticancer drugs or as monotherapy.
• Acute myelogenous leukemia (AML): used in combination with azacitidine or decitabine in adults who cannot undergo intensive chemotherapy.